Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$24,352,461
+$8,785,615 QoQ
Shares Held
96,775
+35.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
2.30%
of 13F equity value
Holder Rank
#546
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rhenman & Partners Asset Management AB holds $173,015,372 across 8 Drug Manufacturers - General names. ABBV ranks #4 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
151,500 | $28,727,430 | |
| 2 | MRK |
Merck & Co., Inc.
|
213,500 | $27,434,750 | |
| 3 | LLY |
ELI LILLY & Co
|
22,315 | $26,765,282 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
96,775 | $24,352,461 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
178,250 | $22,520,105 | |
| 6 | BIIB |
Biogen Inc.
|
94,850 | $20,493,291 | |
| 7 | JNJ |
Johnson & Johnson
|
72,500 | $18,412,825 | |
| 8 | AMGN |
Amgen Inc
|
11,900 | $4,309,228 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,352,461 | 96,775 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $15,566,846 | 71,575 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $25,265,281 | 110,575 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $30,187,027 | 130,375 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $12,877,387 | 69,375 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $18,573,948 | 88,650 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $22,061,455 | 124,150 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $34,953,960 | 177,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $32,417,280 | 189,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $34,507,950 | 189,500 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $25,879,990 | 167,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $22,359,000 | 150,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $20,209,500 | 150,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $24,224,240 | 152,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $21,009,300 | 130,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $20,081,305 | 149,626 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $29,100,400 | 190,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $31,611,450 | 195,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $45,359,000 | 335,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $38,293,850 | 355,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $36,044,800 | 320,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $39,824,960 | 368,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $53,575,000 | 500,000 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $24,525,200 | 280,000 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $29,454,000 | 300,000 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $25,142,700 | 330,000 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||